互联网 qkzz.net
全刊杂志网:首页 > 医药医学 > 《临床肿瘤学医学期刊》 > 2005年第09期
《临床肿瘤学医学期刊》
临床肿瘤学医学期刊2005年第09期封面 购买
收藏
投稿

《临床肿瘤学医学期刊》2005年第09期

combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non
tribute: a phase iii trial of erlotinib hydrochloride (osi-774) combined with carboplatin and paclitaxel chemotherapy in advanced non
mutations in the epidermal growth factor receptor and in kras are predictive and prognostic indicators in patients with non
randomized phase iii trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non
phase ii multicenter study of induction chemotherapy followed by concurrent efaproxiral (rsr13) and thoracic radiotherapy for patients with locally advanced non
randomized phase ii trial of three schedules of pemetrexed and gemcitabine as front-line therapy for advanced non
prognostic importance of preoperative ca-125 in international federation of gynecology and obstetrics stage i epithelial ovarian cancer: an australian multicenter s..
phase i trial of bortezomib and carboplatin in recurrent ovarian or primary peritoneal cancer
study of etanercept, a tumor necrosis factor-alpha inhibitor, in recurrent ovarian cancer
maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study
chemoendocrine therapy for premenopausal women with axillary lymph node
weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks
prospective multicenter validation of the independent prognostic value of the mitotic activity index in lymph node
incidence and prognostic impact of amenorrhea during adjuvant therapy in high-risk premenopausal breast cancer: analysis of a national cancer institute of canada cl..
outcomes from the moving beyond cancer psychoeducational, randomized, controlled trial with breast cancer patients
multicenter phase ii trial of abi-007, an albumin-bound paclitaxel, in women with metastatic breast cancer
randomized controlled trial of an educational intervention for managing fatigue in women receiving adjuvant chemotherapy for early-stage breast cancer
is leptin a mediator of adverse prognostic effects of obesity in breast cancer?
autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti
population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy
role of depression as a predictor of mortality among cancer patients after stem-cell transplantation
survival in patients operated on for pathologic fracture: implications for end-of-life orthopedic care
randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part i: sleep and psychological effects
randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part ii: immunologic effects
proteasome inhibition with bortezomib (ps-341): a phase i study with pharmacodynamic end points using a day 1 and day 4 schedule in a 14-day cycle
associations between drug metabolism genotype, chemotherapy pharmacokinetics, and overall survival in patients with breast cancer
randomized trial comparing two fractionation schedules for patients with localized prostate cancer
is prostate-specific antigen a valid surrogate end point for survival in hormonally treated patients with metastatic prostate cancer? joint research of the european..
occurrence of second cancers in patients treated with radiotherapy for rectal cancer
outcome analysis for patients with elevated serum tumor markers at postchemotherapy retroperitoneal lymph node dissection
durable clinical, cytogenetic, and molecular remissions after allogeneic hematopoietic cell transplantation for refractory sezary syndrome and mycosis fungoides
preoperative psa velocity is an independent prognostic factor for relapse after radical prostatectomy
phase i and pharmacokinetic study of gefitinib in children with refractory solid tumors: a children’s oncology group study
deletions affecting codons 557-558 of the c-kit gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the ..
salvage therapy of progressive and recurrent hodgkin’s disease: results from a multicenter study of the pediatric dal/gpoh-hd study group
late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated pat..
evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the children's oncology group
hyperdiploidy plus nonamplified mycn confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a pediatric oncology group study
favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified mycn neuroblastoma: a children's cancer group study
low-dose chemotherapy for epstein-barr virus
no advantage of dexamethasone over prednisolone for the outcome of standard- and intermediate-risk childhood acute lymphoblastic leukemia in the tokyo children's ca..
stroke as a late treatment effect of hodgkin's disease: a report from the childhood cancer survivor study
minority adult survivors of childhood cancer: a comparison of long-term outcomes, health care utilization, and health-related behaviors from the childhood cancer su..
peer-delivered smoking counseling for childhood cancer survivors increases rate of cessation: the partnership for health study
use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer
lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph..
lack of efficacy of two consecutive treatments of radioimmunotherapy with 131i-cg250 in patients with metastasized clear cell renal cell carcinoma
combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors
prostate-specific antigen nadir and cancer-specific mortality following hormonal therapy for prostate-specific antigen failure
risk-adapted androgen deprivation and escalated three-dimensional conformal radiotherapy for prostate cancer: does radiation dose influence outcome of patients trea..
quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects
patients' perceptions of quality of care for colorectal cancer by race, ethnicity, and language
fatigue in long-term hodgkin's disease survivors: a follow-up study
euthanasia and depression: a prospective cohort study among terminally ill cancer patients
use of a case definition approach to identify cancer-related fatigue in women undergoing adjuvant therapy for breast cancer
explaining differences in attitude toward adjuvant chemotherapy between experienced and inexperienced breast cancer patients
plasma carotenoids and recurrence-free survival in women with a history of breast cancer
racial disparities in treatment and survival among women with early-stage breast cancer
phase i trial of tipifarnib in patients with recurrent malignant glioma taking enzyme-inducing antiepileptic drugs: a north american brain tumor consortium study
phase ii study of erlotinib (osi-774) in patients with advanced hepatocellular cancer
phase i/iia study of cisplatin and gemcitabine as induction chemotherapy followed by concurrent chemoradiotherapy with gemcitabine and paclitaxel for locally advanc..
randomized phase iib trial of blp25 liposome vaccine in stage iiib and iv non
research-design issues in cancer-symptom
effect of age and previous autologous transplantation on nonrelapse mortality and survival in patients treated with reduced-intensity conditioning and allografting ..
longitudinal assessment of hematopoietic abnormalities after autologous hematopoietic cell transplantation for lymphoma
psychoactive medications and risk of delirium in hospitalized cancer patients
phase i trial of recombinant immunotoxin rfb4(dsfv)-pe38 (bl22) in patients with b-cell malignancies
randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with american joint committee on cancer/internati..
biology of desmoplastic melanoma: a case-control comparison with other melanomas
dacarbazine, cisplatin, and interferon-alfa-2b with or without interleukin-2 in metastatic melanoma: a randomized phase iii trial (18951) of the european organisati..
aneurysmal bone cyst: a review of 150 patients
phase ii trial of carcinoembryonic antigen radioimmunotherapy with 131i-labetuzumab after salvage resection of colorectal metastases in the liver: five-year safety ..
raf: a strategic target for therapeutic development against cancer
购买 收藏 投稿
往期回顾
2006年第20期
2006年第02期
2006年第01期
2005年第12期
2005年第11期
2005年第10期
2005年第09期
2005年第08期
2005年第07期
2005年第06期
2005年第05期
2005年第04期
关键字
支持中国杂志产业发展,请购买、订阅纸质杂志,欢迎杂志社提供过刊、样刊及电子版。
关于我们 | 网站声明 | 刊社管理 | 网站地图 | 联系方式 | 中图分类法 | RSS 2.0订阅 | EMS快递查询
全刊杂志赏析网 2017